VANCOUVER, BRITISH COLUMBIA--(Marketwire - Aug. 6, 2007) - Acrongenomics Inc., (OTCBB:AGNM) has appointed Dr. Dimitri Goundis as its Chief Executive Officer (CEO) effective as of September 3, 2007, bringing his important international experience in science, business and management to the company.